ABOUT US
LBE is a pharmaceutical company dedicated to providing advanced formulations for premium healthcare solutions. Our focus is on the development, manufacturing, and commercialization of high-end drug products designed to meet the needs of “safety, efficacy, and ease of use”. LBE also provides comprehensive fill-and-finish CDMO services.。
Pioneering in sophiscated pharmaceutical formulations. LBE is equipped with advanced platforms, including innovative drug-device combination platform, dual-chamber prefilled syringes platform, and microsphere sustained-release formulations platform. We're leading in autoinjector and dual-chamber injection fields.
At LBE, Quality is at the heart of our product development. Leveraging our expertise to accelerate formulation R&D for global partners. We are committed to enhancing lives through professional products and innovative technology.
ABOUT US
LBE is a pharmaceutical company dedicated to providing advanced formulations for premium healthcare solutions. Our focus is on the development, manufacturing, and commercialization of high-end drug products designed to meet the needs of “safety, efficacy, and ease of use”. LBE also provides comprehensive fill-and-finish CDMO services. Pioneering in sophiscated pharmaceutical formulations. LBE is equipped with advanced platforms, including innovative drug-device combination platform, dual-chamber prefilled syringes platform, and microsphere sustained-release formulations platform. We're leading in autoinjector and dual-chamber injection fields.
CDMO SERVICE
LBE has an exceptional professional team and multi-functional production line. With a single-usepreparation system and high-standard quality control system, we offer clients advanced and flexible solutions. Our CDMO service will accelerate the development of formulations for global partners, effectively reduce research and development and production costs. We are committed to benefiting patients.
CDMO SERVICES
LBE has an exceptional professional team and multi-functional production line. With a single-usepreparation system and high-standard quality control system, we offer clients advanced and flexible solutions. Our CDMO service will accelerate the development of formulations for global partners, effectively reduce research and development and production costs. We are committed to benefiting patients.
News&Insights
NEWS
Advancing Pharmaceutical Innovation Through Global Collaboration | LBE Pharma at CPHI Europe 2026
From October 6–8, LBE Pharma showcased its three proprietary technology platforms at Booth 7D139, with global industry partners in discussions on pharmaceutical product development, manufacturing, and potential collaborations.
Meet Us in Milan | LBE Pharma at CPHI 2026, Booth 7D139
LBE Pharma Tech. Co., Ltd. will showcase its core products and integrated CDMO capabilities at CPHI Milan 2026, Booth 7D139. Join us to explore opportunities in innovative formulations, drug delivery technologies and pharmaceutical development and manufacturing.
NMPA Deputy Commissioner Yang Sheng Visits LBE Pharma for Inspection and Guidance, Supporting the Company's Innovation-Driven Development
On June 17, 2026, Mr. Yang Sheng, Member of the Party Leadership Group and Deputy Commissioner of the National Medical Products Administration (NMPA), led a delegation to LBE Pharma for an inspection and guidance visit.
Fujian Governor Zhao Long Visits LBE Pharma for Inspections and Guidance, Charting a New Blueprint for High-Quality Development
On June 3, 2026, Fujian Provincial Governor Zhao Long led a delegation to LBE Pharma for an inspection and research visit, offering strategic guidance and charting the company's future direction. Dr. Du Chuanjie, Chairman and President of the company, accompanied the governor and reported on the company's development strategy, scientific research innovation, and industrialization progress.
Fuzhou SASAC Party Secretary and Director Weng Guoping Leads Delegation to LBE Pharma for Research and Guidance, Praising Hard Core Technology in Advanced Drug Formulations
On the morning of May 13, 2026, Weng Guoping, Party Secretary and Director of the Fuzhou State-owned Assets Supervision and Administration Commission (SASAC), led a delegation to LBE Pharma for a research and guidance visit to gain in-depth understanding of the company's technological innovation and industrialization progress.
Fujian Provincial Medical Products Administration Deputy Director Yu Hua Leads Delegation to LBE Pharma for Research and Guidance, Discussing Cross-Strait Pharmaceutical Integration and Development
On May 11, 2026, Yu Hua, Member of the Party Leadership Group and Deputy Director of the Fujian Provincial Medical Products Administration (FJMPA), led a delegation to LBE Pharma for a thematic inspection and research visit.
JOIN US
We create personalized training programs, blending professional skills and management courses to meet each employee's needs, outlining a unique growth path.Our dual "technology + management" promotion tracks empower employees to shine in their fields, evolving from good to outstanding.
With a global business presence, we dive into international projects, compete with global talents, and stay ahead of industry trends. This offers employees a career full of opportunities and new horizons.
JOIN US
We create personalized training programs, blending professional skills and management courses to meet each employee's needs, outlining a unique growth path.
Our dual "technology + management" promotion tracks empower employees to shine in their fields, evolving from good to outstanding.
With a global business presence, we dive into international projects, compete with global talents, and stay ahead of industry trends. This offers employees a career full of opportunities and new horizons.